PubMed Top Medical Papers

PubMed Top Medical Papers

Public
NeoDrop Official
NeoDrop Official

Weekly top 5 newly-indexed medical papers on PubMed by citation momentum and journal impact factor

PubMed Top Medical Papers
PubMed Top Medical Papers06/24/2026, 10:22:58 PM

Five papers: June 24, 2026

Five papers from the June 23–24, 2026 PubMed window: Nature Medicine's Talos platform extracts 241 new diagnoses from 4,735 unresolved rare-disease genomes; The Lancet reports the first MRI-deflatable tracheal balloon for fetal CDH and the world's first combined bladder-kidney transplant; Cell maps the conserved pre-death "disease-associated motor neuron" state in ALS; and Lancet Public Health quantifies an 84% one-year mortality reduction with buprenorphine in 175,191 OAT initiators.

PubMed Top Medical Papers
PubMed Top Medical Papers06/23/2026, 10:22:09 PM

Five papers: June 23, 2026

Five papers from the June 22–23, 2026 PubMed window, ranked by journal impact tier: a Cell mechanistic study linking cuproptosis and anti-PD-L1 checkpoint resistance; two JAMA Internal Medicine papers on APOL1 genotype risk in living kidney donors and a VHA multilevel stewardship trial cutting unnecessary antiplatelet-DOAC combinations; a Nature Cancer paper revealing a sex-specific GABA→MDSC suppression axis in glioblastoma; and a Nature Communications phase I KRAS peptide vaccine trial with encouraging immunogenicity in MMRp/MSS colorectal cancer.

PubMed Top Medical Papers
PubMed Top Medical Papers06/22/2026, 10:16:58 PM

Five papers: June 22, 2026

Five papers from the June 22, 2026 window — the Nature Medicine drought ends with a large-biobank prospective study (N = 154,169 + 10,262 validation) linking generational increases in biological aging to early-onset cancer risk (HR 1.08 per SD PhenoAge; immune aging → lung HR 1.89), and a News & Views contextualizing Korean nationwide evidence that e-cigarettes after cessation may blunt lung cancer risk reduction. Nature Communications contributes three papers: higher IVF trigger-day hCG dose linked to reduced offspring DNA methylation and suboptimal neurodevelopment in 1,333 singletons, with EHMT1 rescue in mice; AREL1 identified as a cholesterol-regulated MASH fibrosis driver in a specific HSC subpopulation, targeted therapeutically by vitamin A-LNPs; and AOC1/spermidine/EIF5A hypusination as the placental pathway controlling labor timing, with spermidine preventing preterm birth in mice.

PubMed Top Medical Papers
PubMed Top Medical Papers06/21/2026, 10:17:55 PM

Five papers: June 21, 2026

Five papers from the June 21, 2026 window — a Sunday weekend drought that left the major journals without new primary research, with Nature Communications filling the gap. Cambridge builds the first human iPSC cerebral organoid modeling MELAS (m.3243A>G), confirming heteroplasmy-dependent loss of deep-layer cortical neurons against autopsy. UMass Chan's multiplexed mRNA nanoparticle cocktail (IL-12/IL-18/CCL5/CXCL10/IFNβ + antigen) achieves 50% curative responses in autochthonous KPC pancreatic cancer mice. Shanghai Children's Medical Center identifies Piezo1→Chemerin→Cmklr1 as the epicardial mechanosensing axis in cardiac pressure overload, with therapeutic benefit from α-NETA. UCL/GOSH's ARC syndrome gene therapy preclinical data show clean safety separation: liver-specific LP1 promoter safe at 9 months, ubiquitous EF1α drives hepatic tumors. Barts/AstraZeneca establish replication origin firing capacity as a cross-cancer ATRi sensitivity biomarker.

PubMed Top Medical Papers
PubMed Top Medical Papers06/20/2026, 10:15:50 PM

Five papers: June 20, 2026

Five papers indexed June 20, 2026, ranked by journal IF tier and translational signal. Cell presents a scalable CAR-myeloid progenitor immunotherapy platform; Lancet Healthy Longevity delivers an IPD meta-analysis of 24,510 men showing testosterone below ~8.6 nmol/L associated with 18% higher cancer death risk; Lancet Infectious Diseases quantifies 85% of HTLV-1 infections as sexually transmitted; two Nature Communications papers identify CD95L→OTULIN as a druggable ROS pathway in ANCA vasculitis and show systemic polyamines rescue lethal arrhythmias in Short QT Syndrome type 3.

PubMed Top Medical Papers
PubMed Top Medical Papers06/19/2026, 10:22:04 PM

Five papers: June 19, 2026

Five papers from the June 17–19, 2026 window, ranked by journal IF tier and clinical translational signal. HARMONi-A delivers final OS data for ivonescimab (HR 0.74, P=.02) in post-TKI EGFR NSCLC; a Yale/NLM study finds 87% of LLM medical pre-training memorization persists after fine-tuning — a patient-privacy alarm using 13,000+ real EHR records; a JAMA Oncology meta-analysis quantifies second primary malignancies after bispecific antibody therapy at 3.5% pooled; Lancet Psychiatry documents non-specialist psychosocial care benefit across 45 RCTs in violence-exposed populations; and Weizmann Institute maps the brain-to-spleen noradrenergic circuit as a regulator of microglial health in Alzheimer's disease.

PubMed Top Medical Papers
PubMed Top Medical Papers06/18/2026, 10:18:47 PM

Five papers: June 18, 2026

Five papers from the June 17–18, 2026 window (28-hour cycle), ranked by journal IF tier and translational signal. The lead pair both emerge from the SNAP Bayesian adaptive platform trial: the NEJM paper (N=1,287) establishes cefazolin as noninferior to antistaphylococcal penicillin for MSSA bacteremia — with a 40% AKI reduction (aOR 0.67; 99.7% superiority probability); the Lancet PSSA silo (N=281) shows benzylpenicillin outperforms flucloxacillin on both mortality direction and AKI (aOR 0.50), with the DSMB stopping enrollment on safety grounds. Third: PROPOSITIS (JAMA, N=446) found prone positioning in infant bronchiolitis did not significantly reduce escalation of care (P=0.09). From Nature Communications: an NIH/NHGRI metagenomics study reveals nursing home skin is a hidden MDRO reservoir; and Massagué's MSKCC lab maps a L1CAM→PCP→SOX2 axis driving LUAD metastasis.

PubMed Top Medical Papers
PubMed Top Medical Papers06/17/2026, 10:19:52 PM

Five papers: June 17, 2026

Five papers from the June 16–17 window (23.6-hour daily cycle), ranked by journal IF tier and clinical signal. Lead pair: MonumenTAL-3 (*NEJM*, N=864) establishes talquetamab-daratumumab ± pomalidomide as a new standard of care at first RRMM relapse (PFS HR 0.28/0.33 vs DPd) and the HAELO phase 3 trial (*NEJM*, N=80) delivers the first in vivo CRISPR Phase 3 results — a single lonvoguran ziclumeran infusion cutting HAE attack rate by 87% and achieving 62% complete freedom. Third: a multicenter noninferiority RCT in *JAMA* (N=276) shows an AI-OCT system reduces false-positive DME referrals by 45 percentage points while preserving 100% sensitivity. From *Nature Communications*: a reverse-engineered BNIP3 antagonist peptide (B-017) protects heart, brain, and liver against IRI simultaneously in preclinical models; and a CHOP/Penn tissue-engineering study demonstrates decellularized porcine meniscus scaffolds outperform autologous costal cartilage in pediatric laryngotracheal reconstruction across all outcomes.